WHLR – 424B3 February 9, 2026 In SEC https://www.sec.gov/Archives/edgar/data/1527541/000152754126000029/0001527541-26-000029-index.htm #WHLR Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs WHLR – 424B3